Impotence ointment

Details Impotence ointment Impotence ointment

1987-03-02

1989-01-31

Schenkman, Leonard

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514307, 514400, 514502, 514649, 514947, A61K 3147, A61K 3150

Patent

active

048015873

ABSTRACT:
An ointment for relieving impotence. The ointment generally consists of a primary agent, a carrier, and a base, and is applied directly to the penis. The primary agent is a vasodilator selected from the group consisting of papaverine, hydralazine, sodium nitroprusside, phenoxybenzamine and phentolamine. The carrier is used to assist absorption of the primary agent through the skin around the penis. When the primary agent enters the corpora cavernosa within the penis, it causes dilation of the corpora, resulting in an erection.

REFERENCES:
patent: 1176597 (1916-03-01), Pictet
patent: 2561071 (1951-07-01), Prisk
patent: 3795675 (1974-03-01), Laguzzi
patent: 3966724 (1976-06-01), Hughes et al.
patent: 4018927 (1977-04-01), Vorhees
patent: 4055648 (1977-10-01), Sache
patent: 4117841 (1978-10-01), Perrotta et al.
patent: 4311707 (1982-01-01), Birnbaum et al.
patent: 4564010 (1986-01-01), Coughlan et al.

Affiliated with

Also associated with

Rating

Impotence ointment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Impotence ointment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Impotence ointment will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-177575